RSS

Multikine

An update on CEL-SCI’s arbitration with its former clinical research organisation (CRO) has been announced. more

News

The European Patent Office has issued a new patent to biotechnology company, CEL-SCI, for its lead investigational immunotherapy, which is undergoing a Phase III clinical trial for head and neck cancer. more

Technology